Company Update: CVS Caremark Corporation (NYSE:CVS) – EXCLUSIVE-US insurers hold back Lilly’s death-defying diabetes drug

[Reuters – UK Focus] – NEW YORK, Oct (HKSE: 3366-OL.HK – news) 2 (Reuters) – America’s largest health insurers are urging doctors to stick with current standard treatments for diabetes instead of flocking . . . → Read More: Company Update: CVS Caremark Corporation (NYSE:CVS) – EXCLUSIVE-US insurers hold back Lilly’s death-defying diabetes drug Similar Articles: Market Update: Eli Lilly & Company (NYSE:LLY) – EXCLUSIVE-US insurers hold back Lilly’s death-defying diabetes drug Stock Update: CVS Caremark Corporation (NYSE:CVS) – CVS/pharmacy commits to Creating Safer Communities Through Multiple Prescription Drug Abuse Prevention Efforts Company Update: CVS Caremark Corporation (NYSE:CVS) – CVS takes high road in clash with business group